TD SYNNEX Investing Cash Flow increased by 73.9% to -$11.60M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 74.0%, from -$44.53M to -$11.60M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -30.7% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$3.47M | $0.00 | -$949.48M | -$25.22M | -$21.43M | -$30.33M | -$38.53M | -$34.21M | -$30.33M | -$48.62M | -$43.25M | -$67.91M | -$32.89M | -$80.78M | -$12.27M | -$44.53M | -$26.55M | -$105.68M | -$44.41M | -$11.60M |
| QoQ Change | — | +100.0% | — | +97.3% | +15.0% | -41.5% | -27.0% | +11.2% | +11.3% | -60.3% | +11.0% | -57.0% | +51.6% | -145.6% | +84.8% | -263.1% | +40.4% | -298.1% | +58.0% | +73.9% |
| YoY Change | — | — | — | — | -517.0% | — | +95.9% | -35.7% | -41.5% | -60.3% | -12.3% | -98.5% | -8.4% | -66.1% | +71.6% | +34.4% | +19.3% | -30.8% | -262.1% | +74.0% |